ACT Laboratories has announced that it will acquire the Florida operations of Green Scientific Labs Holdings and all related assets. As a result, ACT Laboratories is expecting to be operational in eight states throughout the eastern half of the U.S. by the end of the year. The lab testing company in the legal cannabis and hemp markets will use this acquisition to drive efficiency and predictability across all operational states.

“We continue to take aggressive steps to build ACT Laboratories as the preeminent, multistate cannabis lab testing partner for cultivators, processors, dispensaries and brands in the United States,” said Michael Drozd, CEO of ACT Laboratories. “With the addition of Green Scientific’s operations in Florida, we not only strengthen our footprint, we are adding extensive experience as well as capabilities in hemp testing that will broaden our ability to service customers across markets. As a company, we have the people, technology and financial wherewithal to accelerate our leadership in the industry, and today is another important step in that direction.”

Following the acquisition, Rafael Bombonato, chief compliance officer and interim CEO of Green Scientific, will become vice president of quality for ACT Laboratories and Diana Asensio, currently Green Scientific’s lab director for Florida, will continue in the same role for ACT Laboratories.

“We’re excited to become part of such a strong team with a shared focus on best-in-class testing methods and setting ever-higher standards that can help our customers improve supply chain predictability,” said Rafael Bombonato, chief compliance officer and interim CEO of Green Scientific. “As part of ACT Laboratories, we will bring a suite of capabilities, industry-leading turnaround time and customer service that no other lab in Florida can match.”

ACT Laboratories is the nation’s largest, multi-state cannabis and hemp testing network, providing lab testing services for licensed cultivators and processors.